Trial intelligence / Profile preview

Simvastatin in Refractory Multiple Myeloma

NCT00399867Phase 2Completed

Sponsor
Ludwig Maximilian University of Munich
Start
Apr 2005
Modality
Small Molecules
01

Overview

A Phase 2 trial of simvastatin in multiple myeloma (MM), sponsored by Ludwig Maximilian University of Munich. Started Apr 2005; status: completed.

02

Drugs

simvastatin
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT00399867.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00399867.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call